News Releases

Advanced Search
  • Feb 10, 2020
    Accomplished Biopharmaceutical and Drug Development Executive to Lead the Expansion of Enteris' External and Internal Development Programs

    Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation...

  • Jan 27, 2020
    Enteris recognized for enhancing positive image of small businesses and service to customers

    Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation...

  • Jan 23, 2020
    Trading begins today, January 23, 2020, under the ticker symbol "SWKH"

    SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its shares of common stock will begin trading on the Nasdaq Capital Market beginning...

  • Jan 21, 2020
    Trading to begin on January 23, 2020

    SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, today announced that its shares of common stock have been approved for listing on the...

  • Jan 06, 2020
    A transformational 2019 positions Enteris to capitalize on potential of PeptelligenceĀ®

    Acquired by SWK Holdings Corporation; Now Operating as a Wholly Owned Subsidiary Focused on Advancement of Peptelligence-Driven External Partnerships and Internal Drug Development Pipeline Entered...

Show 5102550100 per page